Effect of cholesterol depletion on the pore dilation of TRPV1

被引:26
|
作者
Jansson, Erik T. [1 ]
Trkulja, Carolina L. [1 ]
Ahemaiti, Aikeremu [1 ]
Millingen, Maria [1 ]
Jeffries, Gavin D. M. [1 ]
Jardemark, Kent [1 ,2 ]
Orwar, Owe [1 ]
机构
[1] Chalmers, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden
[2] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden
来源
MOLECULAR PAIN | 2013年 / 9卷
基金
欧洲研究理事会;
关键词
TRPV1; Cholesterol; M beta CD; Capsaicin; Acidic pH; YO-PRO; Ion-permeability; NMDG; VANILLOID RECEPTOR TRPV1; CAPSAICIN RECEPTOR; ION-CHANNEL; ACTIVATION; SELECTIVITY; HEAT; PAIN; PIPETTE; NEURONS; DOMAIN;
D O I
10.1186/1744-8069-9-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The TRPV1 ion channel is expressed in nociceptors, where pharmacological modulation of its function may offer a means of alleviating pain and neurogenic inflammation processes in the human body. The aim of this study was to investigate the effects of cholesterol depletion of the cell on ion-permeability of the TRPV1 ion channel. The ion-permeability properties of TRPV1 were assessed using whole-cell patch-clamp and YO-PRO uptake rate studies on a Chinese hamster ovary (CHO) cell line expressing this ion channel. Prolonged capsaicin-induced activation of TRPV1 with N-methyl-D-glucamine (NMDG) as the sole extracellular cation, generated a biphasic current which included an initial outward current followed by an inward current. Similarly, prolonged proton-activation (pH 5.5) of TRPV1 under hypocalcemic conditions also generated a biphasic current including a fast initial current peak followed by a larger second one. Patch-clamp recordings of reversal potentials of TRPV1 revealed an increase of the ion-permeability for NMDG during prolonged activation of this ion channel under hypocalcemic conditions. Our findings show that cholesterol depletion inhibited both the second current, and the increase in ion-permeability of the TRPV1 channel, resulting from sustained agonist-activation with capsaicin and protons (pH 5.5). These results were confirmed with YO-PRO uptake rate studies using laser scanning confocal microscopy, where cholesterol depletion was found to decrease TRPV1 mediated uptake rates of YO-PRO. Hence, these results propose a novel mechanism by which cellular cholesterol depletion modulates the function of TRPV1, which may constitute a novel approach for treatment of neurogenic pain.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Role for the TRPV1 Channel in Insulin Secretion from Pancreatic Beta Cells
    Manlio Diaz-Garcia, Carlos
    Morales-Lazaro, Sara L.
    Sanchez-Soto, Carmen
    Velasco, Myrian
    Rosenbaum, Tamara
    Hiriart, Marcia
    JOURNAL OF MEMBRANE BIOLOGY, 2014, 247 (06) : 479 - 491
  • [42] TRPV1 expressed throughout the arterial circulation regulates vasoconstriction and blood pressure
    Phan, Thieu X.
    Ton, Hoai T.
    Gulyas, Hajnalka
    Porszasz, Robert
    Toth, Attila
    Russo, Rebekah
    Kay, Matthew W.
    Sahibzada, Niaz
    Ahern, Gerard P.
    JOURNAL OF PHYSIOLOGY-LONDON, 2020, 598 (24): : 5639 - 5659
  • [43] Investigating potential TRPV1 positive feedback to explain TRPV1 upregulation in airway disease states
    Xu, Jesse
    Ghadiri, Maliheh
    Svolos, Maree
    McParland, Brent
    Traini, Daniela
    Ong, Hui Xin
    Young, Paul M.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2021, 47 (12) : 1924 - 1934
  • [44] Inhibitory effect of positively charged triazine antagonists of prokineticin receptors on the transient receptor vanilloid type-1 (TRPV1) channel
    De Petrocellis, Luciano
    Moriello, Aniello Schiano
    Byun, Joon Seok
    Sohn, Joo Mi
    Lee, Jae Yeol
    Vazquez-Romero, Ana
    Garrido, Maria
    Messeguer, Angel
    Zhang, Fang-Xiong
    Zamponi, Gerald W.
    Deplano, Alessandro
    Congiu, Cenzo
    Onnis, Valentina
    Balboni, Gianfranco
    Di Marzo, Vincenzo
    PHARMACOLOGICAL RESEARCH, 2015, 99 : 362 - 369
  • [45] Advances in the development of TRPV1 antagonists
    Correll, Craig C.
    Palani, Anandan
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (06) : 783 - 795
  • [46] The skinny on TRPV1
    Cioffi, Donna L.
    CIRCULATION RESEARCH, 2007, 100 (07) : 934 - 936
  • [47] Painful toxins acting at TRPV1
    Cromer, Brett A.
    McIntyre, Peter
    TOXICON, 2008, 51 (02) : 163 - 173
  • [48] Analgesic potential of TRPV1 antagonists
    Kym, Philip R.
    Kort, Michael E.
    Hutchins, Charles W.
    BIOCHEMICAL PHARMACOLOGY, 2009, 78 (03) : 211 - 216
  • [49] TRPV1 in Dry Eye Disease
    Gou, Qingqing
    Song, Zhi
    Gong, Yu
    Li, Jiawen
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (05):
  • [50] Inhibition of TRPV1 by an antagonist in clinical trials is dependent on cholesterol binding
    Brandwine-Shemmer, Tal
    Minke, Baruch
    Levitan, Irena
    CELL CALCIUM, 2024, 124